Economic Analysis of Robotic Rectal Resection in German Health Care System

Completed

• Conditions: Rectal Cancer

• Registration Number: NCT06113796
• Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Brief Summary

Analysis of cost effectiveness of robotic rectal resection, either sphincter preserving or abdominoperineal extirpation, in the German diagnosis related groups (DRG) system.

Detailed Description

Robotic surgery has many well-known benefits for patients and surgeons, while it comes with higher acquisition and maintenance costs. On the other hand, a higher proportion of minimally invasive procedures can save costs by reducing complications, decreasing hospital stays due to lower morbidity, and saving personnel.

To what extent can robotic surgery be cost-covering or even profitable, depending on the postoperative course? This question is investigated under the conditions of the German DRG system.

Study Timeline

• Study Start: 2018-01-01
• Primary Completion: 2019-12-31
• Study Completion: 2021-12-31
• Study First Submitted: 2023-10-04
• Status Verified: 2023-11
• Study First Submitted QC: 2023-11-01
• Last Update Submitted: 2023-11-01
• Study First Posted: 2023-11-02
• Last Update Posted: 2023-11-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 65

Inclusion Criteria

• 18y
• histologically proven rectal cancer with curative therapeutic approach
• suitable for minimally-invasive surgery

Exclusion Criteria

• no rectal cancer
• primary open surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Costs of treatment	1 year	costs caused by the case

Secondary Outcome Measures

Name	Time	Method
Major Complication	30 days postoperatively	Clavin Dindo Score ≥ 3
Length of Hospital Stay	3 months	Hospital Stay after Surgery
30-days Readmission	30 days	Readmission within 30 days after Surgery

Trial Locations

Locations (1)

University of Hamburg Medical Institutions; 🇩🇪 Hamburg, Germany